202 related articles for article (PubMed ID: 28820074)
21. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of exosome biogenesis by adiponectin, a circulating factor secreted from adipocytes.
Kita S; Shimomura I
J Biochem; 2021 Mar; 169(2):173-179. PubMed ID: 32979268
[TBL] [Abstract][Full Text] [Related]
23. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2.
Fukuda S; Kita S; Obata Y; Fujishima Y; Nagao H; Masuda S; Tanaka Y; Nishizawa H; Funahashi T; Takagi J; Maeda N; Shimomura I
J Biol Chem; 2017 May; 292(19):7840-7849. PubMed ID: 28325833
[TBL] [Abstract][Full Text] [Related]
24. [Adiponectin and cardiovascular diseases].
Zhang P; Wang NP
Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):149-52. PubMed ID: 17633232
[No Abstract] [Full Text] [Related]
25. Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.
Heiker JT; Kosel D; Beck-Sickinger AG
Biol Chem; 2010 Sep; 391(9):1005-18. PubMed ID: 20536390
[TBL] [Abstract][Full Text] [Related]
26. Multifaceted roles of adiponectin in cancer.
Hebbard L; Ranscht B
Best Pract Res Clin Endocrinol Metab; 2014 Jan; 28(1):59-69. PubMed ID: 24417946
[TBL] [Abstract][Full Text] [Related]
27. High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
Nomura-Nakayama K; Adachi H; Miyatake N; Hayashi N; Fujimoto K; Yamaya H; Yokoyama H
PLoS One; 2018; 13(5):e0195066. PubMed ID: 29718962
[TBL] [Abstract][Full Text] [Related]
28. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
29. Adiponectin--a key adipokine in the metabolic syndrome.
Whitehead JP; Richards AA; Hickman IJ; Macdonald GA; Prins JB
Diabetes Obes Metab; 2006 May; 8(3):264-80. PubMed ID: 16634986
[TBL] [Abstract][Full Text] [Related]
30. Mapping and engineering the interaction between adiponectin and T-cadherin.
Pascolutti R; Erlandson SC; Burri DJ; Zheng S; Kruse AC
J Biol Chem; 2020 Feb; 295(9):2749-2759. PubMed ID: 31915248
[TBL] [Abstract][Full Text] [Related]
31. Adiponectin signaling and metabolic syndrome.
Fu Y
Prog Mol Biol Transl Sci; 2014; 121():293-319. PubMed ID: 24373241
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of adiponectin receptors in osteoarthritic chondrocytes.
Wang Q; Cai J; Wang J; Xiong C; Yan L; Zhang Z; Fang Y; Zhao J
Cell Biochem Biophys; 2014 Sep; 70(1):491-7. PubMed ID: 24888493
[TBL] [Abstract][Full Text] [Related]
33. Adiponectin: mechanistic insights and clinical implications.
Turer AT; Scherer PE
Diabetologia; 2012 Sep; 55(9):2319-26. PubMed ID: 22688349
[TBL] [Abstract][Full Text] [Related]
34. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari AE; Jain SK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic perspectives for adiponectin: an update.
Li FY; Lam KS; Xu A
Curr Med Chem; 2012; 19(32):5513-23. PubMed ID: 22876919
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin and cardiovascular health: an update.
Hui X; Lam KS; Vanhoutte PM; Xu A
Br J Pharmacol; 2012 Feb; 165(3):574-90. PubMed ID: 21457225
[TBL] [Abstract][Full Text] [Related]
37. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.
Wang Y; Ma XL; Lau WB
Trends Endocrinol Metab; 2017 Jul; 28(7):519-530. PubMed ID: 28473178
[TBL] [Abstract][Full Text] [Related]
39. A potential determinant role of adiponectin and receptors for the early embryo development in PCOS patients with obesity hinted by quantitative profiling.
Zhang N; Hao C; Liu X; Zhang S; Zhang F; Zhuang L; Zhao D
Gynecol Endocrinol; 2017 Feb; 33(2):113-118. PubMed ID: 27597432
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin-Resistance in Obesity.
Engin A
Adv Exp Med Biol; 2017; 960():415-441. PubMed ID: 28585210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
